Komori
Japan Lifeline (7575) · InitiativeAchieved

Financing through stock acquisition rights with adjustment clauses for the exercise price

First written in FY2018-Q3. 1 of 3 entries say "Advanced", first in FY2018. Latest entry: FY2019.

3entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2018-Q3AdvancedFY2018 – FY20192018: 220182019: 12019
Same theme, other companies

24 other companies' latest entry also says "Achieved".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 69 companies compared. The sentences above are computed from all 69.
Full recordFilings, disclosures and news, newest first
  1. FY2019AchievedAnnual report

    「The Company believes that the funds required for the large-scale investments anticipated at this stage have been largely secured through the funds raised by the second series of stock acquisition rights, and that it has achieved its objective to a certain extent of securing funds for medium- to long-term growth while strengthening its financial base.」

    The Company stated that the funds required for large-scale investments had been largely secured through the second series of stock acquisition rights, and ended the fundraising program by acquiring and cancelling the remaining 10,000 third-series stock acquisition rights.
  2. FY2018AdvancedAnnual report

    「During the fourth quarter accounting period and the 38th fiscal year, stock acquisition rights attached to bonds with stock acquisition rights and other instruments containing exercise price adjustment clauses were exercised as follows.」

    30,000 stock acquisition rights were exercised, 6,000,000 shares were delivered and ¥13.815 billion was raised. The fundraising intended for growth investments and other purposes moved into the execution stage.
  3. FY2018-Q3First statedAnnual report

    「The number of shares underlying these stock acquisition rights has been determined as 3,000,000 shares for the second series of stock acquisition rights and 1,000,000 shares for the third series. Each stock acquisition right represents 100 underlying shares.」

    The Company issued the second and third series of stock acquisition rights, with exercise periods from 5 January 2018 to 30 December 2020. The exercise price was adjusted based on 92% of the Tokyo Stock Exchange closing price, and the minimum proceeds if all rights were exercised were approximately ¥9.197 billion for the second series and approximately ¥3.066 billion for the third series.
Moved together

"Medical Device Business Covering Both Trading and Manufacturing" moved the same way as this thread, in the same document, in 2 of its 3 moves.

222222★123456
  1. ★This thread
  2. 1Medical Device Business Covering Both Trading and Manufacturing2×
  3. 2Absorbing Declines in Product Prices and Achieving Stable Growth2×
  4. 3Expansion of Unique, High-Value-Added Proprietary Products2×
  5. 4Expansion of medical devices beyond the cardiovascular field and entry into the gastrointestinal field2×
  6. 5Board Oversight and Auditing by Independent Outside Officers2×
  7. 6Introducing the latest medical devices from overseas manufacturers to Japan2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Japan Lifeline's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.